Polycyclic organic compounds, Experimental cancer drugs, matrixscientific.com, Three-membered rings, Antineoplastic and immunomodulating drugs, Organofluorides, Tetracyclic compounds
Categories
Cyclic compounds (1)
Cycloalkanes (1)
Cyclopropanes (1)
Halides (1)
Organohalides (1)
Pharmaceuticals (1)
Piperazines (1)
Zosuquidar Trihydrochloride
(167465-36-3)
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Related Results:
1,2,3,4-Tetrahydroquinoline
(635-46-1)
tetrahydroquinoline
2,6-DIMETHYLQUINOLINE
(877-43-0)
2,6-dimethyl quinoline
4-Aminoquinoline
(578-68-7)
4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections. Examples include amodiaquine, chloroquine, and hydroxychloroquine.
6-Methoxyquinoline
(5263-87-6)
6-methoxyquinoline hydrochloride
PYRAZINE
(290-37-9)
Pyrazine is a heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine is a symmetrical molecule with point group D2h. Pyrazine is less basic than pyridine, pyridazine and pyrimidine.
2,5-DIMETHYLPYRAZINE
(123-32-0)
2,5-DMP · 2,6-dimethylpyrazine
Related searches
